• GE Healthcare to Acquire Whatman

    News & views

    GE Healthcare to Acquire Whatman

    GE Healthcare, a unit of General Electric Company and Whatman plc have reached agreement on the terms of a recommended acquisition of Whatman
    by GE Healthcare.
    The terms of the transaction, subject to approval by Whatman shareholders as well as customary regulatory approvals* value the global supplier of filtration products and technologies at approximately
    £363 million (approximately $713 million.) Joe Hogan, President and CEO GE Healthcare, commented, “Whatman is a great company with an outstanding track record of innovation, a strong reputation and brand with the research community, and highly talented employees.
    Whatman’s product offerings are highly complementary with our Life Sciences business; we believe that combining the skills and knowledge of the two businesses will create significant added value for our customers. Life Sciences is a key area of growth for GE Healthcare
    and expanding our skill base and product offerings in this area supports our vision of helping our customers to diagnose and treat disease earlier.”
    Commenting on the acquisition, Kieran Murphy, Chief Executive Officer of Whatman, said, “Whatman will benefit significantly from the
    business process expertise within GE Healthcare and in addition, Whatman’s product opportunities within the pharmaceutical, diagnostic and forensics markets will have a greater chance of success within
    the larger GE Healthcare group. The Whatman management team very much looks forward to working with the GE Healthcare leadership to maximise the potential of this great business.”
    Peter Ehrenheim, President and CEO of GE Healthcare’s Life Sciences business, said, “Whatman’s expertise and reputation in filtration
    technologies and sample preparation is a great fit for our Life Sciences business because it brings new technologies that are fundamental to helping researchers increase their understanding
    of the role of genes and proteins in disease.
    We believe that combining the skills of the two companies will enable GE Healthcare to create strong added value for customers in biomedical
    and drug discovery research.”
    *(at the time of going to press).

    Digital Edition

    Lab Asia 31.6 Dec 2024

    December 2024

    Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...

    View all digital editions

    Events

    Smart Factory Expo 2025

    Jan 22 2025 Tokyo, Japan

    Instrumentation Live

    Jan 22 2025 Birmingham, UK

    SLAS 2025

    Jan 25 2025 San Diego, CA, USA

    Arab Health

    Jan 27 2025 Dubai, UAE

    Nano Tech 2025

    Jan 29 2025 Tokyo, Japan

    View all events

    Great Job...
    The latest issue will be with you shortly
    Sign up to Labmate for FREE.
    Register and get the eBulletin, a Monthly email packed with the latest Laboratory products, news and services. Join us and get the latest Laboratory information first.